Search

everythinglearnresearchcommunity

for

Search:↓

Cimetidine did not reduce hair growth in women with hirsutism.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Metformin may improve acanthosis nigricans by reducing insulin resistance.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Effective PCOS treatments require targeting specific signaling pathways.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Eating a high-glycemic diet may worsen acne by increasing certain protein levels and expressions in the skin.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

Menopause affects hair and skin; more research needed for treatment.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.